Richard Steiner of Pharmatech Associates makes the case for pharmaceutical continuous manufacturing (PCM), how it supports specific business needs and the way to implement it. He writes that it remains a deeply entrepreneurial decision whether to implement PCM, as each level in the organization and each step in the value-adding process is involved.
Our unique approach can help your company navigate the complexities of launching a drug, biologic or medical device into multiple markets. The first step? Connecting. Simply fill out our form and a representative will follow-up shortly.
1.877.787.0177
510.732.0177
22320 Foothill Blvd. Suite 330, Hayward CA 94541
